The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

BrainStorm Cell Therapeutics - Developing Cellular Therapies for Neurodegenerative Diseases

SNNLive spoke with Ralph Zern, MD, MHSc, COO and CMO of BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), at the BIO CEO & Investor Conference 2019 in New York, NY.

Share With

Wednesday, March 13, 2019

   

© 2019 Stock News Now